JNJ-74856665
JNJ-74856665 is an orally bioavailable, potent, and selective DHODH inhibitor with IC50 of 0.40 nM. JNJ-74856665 shows favorable physicochemical properties and has been selected for clinical development in patients with AML and myelodysplastic syndromes (MDS) .
Product Specifications
Purity
0.98
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1050119-01 100 mg
Tert-Butyl 2- (((5-chloropyrimidin-2-yl) oxy) methyl) piperidine-1-carboxylate
Sign In for Pricing
View Details OR1050119-02 250 mg
Tert-Butyl 2- (((5-chloropyrimidin-2-yl) oxy) methyl) piperidine-1-carboxylate
Sign In for Pricing
View Details 
LV784901 1.0 µg DNA
RPS28P6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details